Shares of Hoya Corp. (OTCMKTS:HOCPY - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $166.07 and traded as low as $163.22. Hoya shares last traded at $165.3350, with a volume of 27,343 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded shares of Hoya from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, September 30th. One equities research analyst has rated the stock with a Strong Buy rating. According to MarketBeat, Hoya presently has a consensus rating of "Strong Buy".
Read Our Latest Analysis on Hoya
Hoya Stock Performance
The stock has a fifty day simple moving average of $155.28 and a two-hundred day simple moving average of $166.07. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.20 and a current ratio of 4.91. The stock has a market capitalization of $55.36 billion, a price-to-earnings ratio of 32.80, a P/E/G ratio of 3.48 and a beta of 0.97.
Hoya (OTCMKTS:HOCPY - Get Free Report) last announced its quarterly earnings data on Friday, October 30th. The technology company reported $1.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.28 by $0.05. Hoya had a return on equity of 25.78% and a net margin of 27.58%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.67 billion. Analysts forecast that Hoya Corp. will post 5.26 earnings per share for the current fiscal year.
Hoya Company Profile
(
Get Free Report)
HOYA Corporation is a Japan-based technology and healthcare company that develops and manufactures optical products and precision components. Founded in 1941 as an optical glass manufacturer, the company has expanded into medical devices, vision care, and advanced technologies used in semiconductor production and other industrial applications.
Through its Life Care businesses, HOYA provides prescription eyeglass lenses, contact lenses, intraocular lenses used in cataract surgery, and medical equipment such as endoscopic systems.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.